Who is the CEO of NVAX? | Glauxie AI

Q: Who is the CEO of NVAX?

Novavax, Inc. (NVAX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO John Charles Jacobs. Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine... Employees: 749.

Q: What does NVAX company do?

Learn what NVAX does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling NVAX?

Track recent insider buys and sells for NVAX with transaction details, amounts, and trends.

Q: What sector is NVAX in?

Find NVAX sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of NVAX?

🦉

Novavax, Inc. (NVAX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOJohn Charles Jacobs

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials,...

Key Executives

Name	Title
Elaine O'Hara	Executive Vice President & Chief Strategy Officer
Erika S. Trahan	Associate Director of Investor & Public Relations
Ian J. Watkins	Executive Vice President & Chief Human Resources Officer
James Patrick Kelly	Executive Vice President, Chief Financial Officer & Treasurer
John Charles Jacobs	President, Chief Executive Officer & Director
Luis Sanay	Vice President of Investor Relations

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

NVAX Profile Financials

What does NVAX company do? Are insiders buying or selling NVAX? What sector is NVAX in?